- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01574482
Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (Italy)
November 23, 2016 updated by: Danone Research
Effects of the Consumption of a Plant Sterols-enriched Dairy Fermented Product on Hypercholesterolemia Management in Hypercholesterolemic Adults
The purpose of this study is to investigate the cholesterol lowering effect of a drinkable low fat fermented milk enriched with plant sterol after 3 and 6 weeks of daily consumption in mildly hypercholesterolemic people treated or not by statins
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
116
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Perugia, Italy, 06129
- Ospedale Silvestrini
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- male and female aged 20-75 years; BMI between 19 and 30 kg/m2 , LDL-cholesterol plasma level between 130 mg/dL to 190 mg/dL (bounds included) with or without any statin monotherapy, with stabilized hypercholesterolemia (since more than 3 months), accepting to follow the dietary recommendations advisable for hypercholesterolemic patient (NCEP-ATP III guidelines), used to consume dairy products, agreeing to a written informed consent, for female: effective contraceptive methods used
Exclusion Criteria:
- Subject with plasma triglycerides (TG) levels > or = 350 mg/dL, with any cardiovascular event in the last 6 months, Subject taking any drugs affecting lipid metabolism (including hypocholesterolemic treatment) other than statin in monotherapy, Diabetic (type I and type II), smoking strictly more than 20 cigarettes/day, presenting known allergy or hypersensitivity to milk proteins, and soy, receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters, with renal failure or any other metabolic disorder which could interfere with the evaluation of efficiency or safety of the product , pregnant and breast feeding women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1 = Tested product
|
1 = Intervention 1 (1 test product/day)
|
Placebo Comparator: 2 = Control product
|
2 = Intervention 2 (1 control product/day)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Actual)
April 1, 2007
Study Completion (Actual)
June 1, 2007
Study Registration Dates
First Submitted
April 7, 2012
First Submitted That Met QC Criteria
April 7, 2012
First Posted (Estimate)
April 10, 2012
Study Record Updates
Last Update Posted (Estimate)
November 25, 2016
Last Update Submitted That Met QC Criteria
November 23, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NU216
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mildly Hypercholesterolemic Subjects
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsFrance
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsCanada
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsUnited Kingdom
-
Danone ResearchCompletedMild Hypercholesterolemic SubjectsGermany
-
Danone JapanCompletedNormal and Mild Hypercholesterolemic SubjectsJapan
-
Unilever R&DCompletedHealthy | Mildly Elevated Cholesterol LevelsSweden
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
Novartis PharmaceuticalsCompletedHeart Failure With Reduced Ejection Fraction (HFrEF) | or Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)Netherlands, United States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
Clinical Trials on 1- plain low-fat dairy fermented product (drinkable) enriched with plant sterols-esters (1,6g /day equivalent as free sterols).
-
Danone ResearchCompletedMild Hypercholesterolemic SubjectsGermany
-
Danone ResearchCompletedHypercholesterolemiaUnited States
-
Danone JapanCompletedHealthy | Mild HypercholesterolemiaJapan
-
Danone JapanCompletedNormal and Mild Hypercholesterolemic SubjectsJapan
-
Danone SpainCompletedHypercholesterolemiaSpain
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsCanada
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsFrance
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsUnited Kingdom